| Age at diagnosis |
|
| Mean (SD), y |
61.7 (14.0) |
| Median (range), y |
64 (41-80) |
| Time to diagnosis, mean (range) |
3.7 y (1 mo-20 y) |
| Race |
|
| White |
25 (93) |
| African American |
2 (7) |
| Site of lichen planus disease |
|
| Vulvar mucosa |
27 (100) |
| Vulvar mucosa only |
7 (26) |
| Vaginal mucosa |
6 (22) |
| Oropharyngeal mucosa |
19 (70) |
| Skin |
5 (19) |
| Disease symptoms |
|
| Pruritus |
11 (41) |
| Burning sensation |
11 (41) |
| Pain |
8 (29) |
| Erosions |
|
| Erythema |
8 (30) |
| Wickham striae |
7 (26) |
| Scarring |
7 (26) |
| Erythema and Wickham striae |
5 (19) |
| Biopsy site |
|
| Oral |
8 (30) |
| Vulvar |
6 (22) |
| Cutaneous |
4 (15) |
| Vulvar (previous physician) |
5 (19) |
| Oral (previous physician) |
2 (7) |
| Cutaneous (previous physician) |
1 (4) |
| Unspecified |
1 (4) |
| Histopathologic characteristics |
|
| Bandlike infiltrate at dermoepidermal junction |
11 (41) |
| Foci of lichenoid inflammation |
5 (19) |
| Unspecific inflammation |
4 (15) |
| Ulceration and lichenoid mucositis |
3 (11) |
| Lichenoid mucositis |
3 (11) |
| Unspecified |
1 (4) |
| Criteria for diagnosis |
|
| Clinical and histologic |
26 (96) |
| Clinical |
1 (4) |
| Other conditions |
|
| Vulvodynia |
4 (15) |
| Thyroid disease |
2 (7) |
| Psoriasis |
1 (4) |
| Rosacea conjunctivitis |
1 (4) |
| Fibromyalgia |
1 (4) |
| Herpes simplex virus type 1/2 |
1 (4) |
| Previous medications |
|
| Clobetasol |
8 (30) |
| Prednisone |
6 (22) |
| Methotrexate |
5 (19) |
| Hydroxychloroquine |
4 (15) |
| Betamethasone |
3 (11) |
| Clotrimazole |
3 (11) |
| Lidocaine |
2 (7) |
| Mycophenolate mofetil |
2 (7) |
| Fluocinonide |
2 (7) |
| Conjugated estrogens |
2 (7) |
| Acitretin |
1 (4) |
| Triamcinolone |
1 (4) |
| Topical cyclosporine |
1 (4) |
| Hydrocortisone suppository |
1 (4) |
